Analytical Data
-
Gene name
TRAF4
- Application
-
Alternative Names
TRAF4；CART1；MLN62；RNF83；TNF receptor-associated factor 4
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BUZ4
-
Expression Region
1-470aa
-
AA Sequence
MPGFDYKFLE KPKRRLLCPL CGKPMREPVQ VSTCGHRFCD TCLQEFLSEG VFKCPEDQLP LDYAKIYPDP ELEVQVLGLP IRCIHSEEGC RWSGPLRHLQ GHLNTCSFNV IPCPNRCPMK LSRRDLPAHL QHDCPKRRLK CEFCGCDFSG EAYESHEGMC PQESVYCENK CGARMMRRLL AQHATSECPK RTQPCTYCTK EFVFDTIQSH QYQCPRLPVA CPNQCGVGTV AREDLPGHLK DSCNTALVLC PFKDSGCKHR CPKLAMARHV EESVKPHLAM MCALVSRQRQ ELQELRRELE ELSVGSDGVL IWKIGSYGRR LQEAKAKPNL ECFSPAFYTH KYGYKLQVSA FLNGNGSGEG THLSLYIRVL PGAFDNLLEW PFARRVTFSL LDQSDPGLAK PQHVTETFHP DPNWKNFQKP GTWRGSLDES SLGFGYPKFI SHQDIRKRNY VRDDAVFIRA AVELPRKILS
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TRAF4 (TNF Receptor-Associated Factor 4) is a member of the TRAF protein family, which plays a crucial role in mediating signaling pathways related to immune responses, cell survival, and differentiation. It is primarily involved in the signaling of TNF receptor superfamily members and various other receptors, thus influencing important biological processes such as inflammation and apoptosis. Emerging studies have highlighted TRAF4's significant involvement in various diseases, including cancer, autoimmune disorders, and viral infections. Given its pivotal function in modulating immune responses and cell fate decisions, TRAF4 has attracted considerable attention for its potential as a therapeutic target. Research on TRAF4 recombinant proteins has focused on understanding its structural properties, interaction mechanisms with upstream receptors and downstream signaling molecules, and its regulatory role in cellular processes. By utilizing recombinant TRAF4 proteins, scientists aim to elucidate the molecular pathways involving this protein and develop targeted interventions that could alter its activity for therapeutic benefits. As such, TRAF4 represents a promising candidate for future drug development, particularly in contexts where modulation of immune responses is critical.
